Focused on restoring interrupted central nervous system circuitry through engineered neural tissue constructs designed for structural integration and functional reconnection.

• Circuit-level restoration rather than compensation

• Human-relevant three-dimensional tissue architecture

• Electrophysiologic performance validation

• Scalable manufacturing from inception

• Pathway toward cGMP-compliant production

Peripheral Nerve Repair

• Functional reconnection across segmental nerve gaps

• Quantitative intraoperative and post-repair assessment

• Accelerated path to clinical manufacturability

Neuromuscular Interface Restoration

• Biohybrid integration of engineered neural tissue with muscle

• Closed-loop functional assessment

Neurodegenerative Disease Modeling

• Human 3D neural systems for predictive testing

• Replacement of 2D culture systems

• Three-dimensional engineered neural tissue test beds

• Defined structural and electrophysiologic release criteria

• Reduced reliance on animal models

• Increased predictive validity

For academic and industry partners:

• Electrophysiologically active 3D human neural test beds, manufactured under defined, quality-controlled parameters to accelerate hypothesis validation and improve translational confidence

• Quantitative structural and functional release criteria ensuring reproducibility, consistency, and performance validation

• Human-relevant platforms that replace 2D culture and reduce animal dependence, increasing predictive translational fidelity

• Seamless alignment between discovery and scalable manufacturing, eliminating downstream process re-engineering

• Shared, capital-efficient biomanufacturing access for academic, clinical, and industry partners

• Compressed discovery-to-clinic timelines through integrated automation, quality systems, and translational infrastructure